The Effect of a New
behavioral tests
experimental ischemic stroke
inflammation
neuroprotective activity
transient MCAO
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
26 Aug 2022
26 Aug 2022
Historique:
received:
22
07
2022
revised:
20
08
2022
accepted:
23
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
Ischemic stroke triggers a whole cascade of pathological changes in the brain, one of which is postischemic inflammation. Since in such cases thrombolytic therapy is often not possible, methods that modulate inflammation and affect microglia become particularly interesting. We synthesized 3-(2-oxo-4-phenylpyrrolidin-1-yl)propane-1-sulfonate calcium(II) (Compound
Identifiants
pubmed: 36080256
pii: molecules27175488
doi: 10.3390/molecules27175488
pmc: PMC9457934
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Cytokines
0
Neuroprotective Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : the Russian Science Foundation
ID : 21-73-20250
Organisme : the Russian Foundation of Basic Research
ID : 20-03-00858
Références
Molecules. 2021 Oct 11;26(20):
pubmed: 34684709
Pharmacol Biochem Behav. 2013 Apr;105:183-92
pubmed: 23474372
Stroke. 2012 Nov;43(11):3063-70
pubmed: 22933588
Life (Basel). 2022 Jun 17;12(6):
pubmed: 35743941
Neuropsychopharmacology. 2017 Jan;42(1):81-98
pubmed: 27555379
J Alzheimers Dis. 2012;32(4):793-887
pubmed: 22886028
Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2078-2096
pubmed: 29551729
Stroke. 2015 Aug;46(8):2271-6
pubmed: 26130091
Bull World Health Organ. 2016 Sep 1;94(9):634-634A
pubmed: 27708464
Pharmaceuticals (Basel). 2012 Oct 23;5(10):1128-46
pubmed: 24281261
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
Front Neurol. 2020 Jul 17;11:623
pubmed: 32765394
Cent Nerv Syst Agents Med Chem. 2011 Jun 1;11(2):164-73
pubmed: 21521168
Cells. 2021 Dec 16;10(12):
pubmed: 34944064
J Neuroinflammation. 2021 Mar 23;18(1):81
pubmed: 33757565
Stroke. 2010 Dec;41(12):2889-93
pubmed: 21051671
Ann Rehabil Med. 2012 Jun;36(3):303-10
pubmed: 22837964
Front Cell Neurosci. 2021 Nov 17;15:755955
pubmed: 34867201
Stroke. 2016 Feb;47(2):498-504
pubmed: 26732561
Front Aging Neurosci. 2018 Nov 02;10:285
pubmed: 30455639
Sci Rep. 2017 Aug 30;7(1):10052
pubmed: 28855592
Curr Neurovasc Res. 2007 Feb;4(1):31-7
pubmed: 17311542
Stroke. 2003 Mar;34(3):671-5
pubmed: 12624290
J Neurosci. 2018 Nov 21;38(47):10168-10179
pubmed: 30291203
CNS Neurosci Ther. 2019 Apr;25(4):532-543
pubmed: 30444079
Dement Geriatr Cogn Disord. 2003;16(1):52-6
pubmed: 12714801
Nature. 2019 Jan;565(7738):246-250
pubmed: 30602786
Redox Biol. 2019 Jun;24:101223
pubmed: 31141786
Inflammopharmacology. 2020 Oct;28(5):1283-1292
pubmed: 32279140
Prog Neurobiol. 2014 Apr;115:157-88
pubmed: 24361499
J Neurochem. 2015 Dec;135(6):1189-202
pubmed: 26376347
J Neurosci Methods. 2003 Sep 30;128(1-2):183-90
pubmed: 12948561
Int J Stroke. 2019 Aug;14(6):574-591
pubmed: 30940045
Transl Stroke Res. 2018 Aug;9(4):417-425
pubmed: 29178027
Sci Rep. 2019 Aug 21;9(1):12221
pubmed: 31434993
Front Pharmacol. 2021 May 14;12:638209
pubmed: 34054520